Comparative Pharmacology
Head-to-head clinical analysis: CALCIUM ACETATE versus VELPHORO.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CALCIUM ACETATE versus VELPHORO.
CALCIUM ACETATE vs VELPHORO
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Calcium acetate binds with dietary phosphate in the gastrointestinal tract, forming insoluble calcium phosphate that is excreted in feces, thereby reducing serum phosphate levels.
Iron-based phosphate binder that forms non-absorbable complexes with dietary phosphate in the gastrointestinal tract, reducing serum phosphate levels.
668 mg (169 mg calcium) to 2 g (500 mg calcium) orally three times daily with meals, titrated to maintain serum phosphorus within target range (2.5-4.5 mg/dL). Maximum dose typically 4 g calcium per day.
1-2 tablets (500-1000 mg iron) orally three times daily with meals; titrate to achieve serum phosphorus target.
None Documented
None Documented
Clinical Note
moderateCalcium acetate + Clodronic acid
"The serum concentration of Clodronic acid can be decreased when it is combined with Calcium acetate."
Clinical Note
moderateCalcium acetate + Tranilast
"The therapeutic efficacy of Tranilast can be decreased when used in combination with Calcium acetate."
Clinical Note
moderateCalcium acetate + Alendronic acid
"The serum concentration of Alendronic acid can be decreased when it is combined with Calcium acetate."
Clinical Note
moderateNot applicable for calcium acetate as a compound; serum calcium half-life is approximately 4–6 hours after absorption, reflecting rapid redistribution and renal clearance.
Not applicable (non-absorbed drug acting locally in GI tract; no systemic half-life).
Calcium acetate dissociates in the gastrointestinal tract; calcium is absorbed or excreted in feces, acetate is metabolized. Renal excretion accounts for <20% of absorbed calcium; biliary/fecal elimination is minimal. Unabsorbed calcium acetate is eliminated in feces.
Primarily fecal as unabsorbed drug; negligible renal excretion (<0.1%).
Category C
Category C
Phosphate Binder
Phosphate Binder
Calcium acetate + Technetium Tc-99m medronate
"The serum concentration of Technetium Tc-99m medronate can be decreased when it is combined with Calcium acetate."